Global Transcatheter Treatment Device Market

The global transcatheter treatment device market is anticipated to increase by USD 12 billion till 2028 at an average annual growth of 14.3 percent as per the latest report by Gen Consulting Company.

This industry report offers market estimates of the global market, followed by a detailed analysis of the product, procedure approach, valve type, and region. The global market data on transcatheter treatment device can be segmented by product: transcatheter aortic valve repair and replacement devices (TAVR/TAVI), transcatheter mitral valve repair (TMVR) devices, transcatheter tricuspid valve repair (TTVR) devices. According to the research, the transcatheter aortic valve repair and replacement devices (TAVR/TAVI) segment had the largest share in the global transcatheter treatment device market. Transcatheter treatment device market is further segmented by procedure approach: transfemoral, transapical, transaortic. In 2021, the transfemoral segment made up the largest share of revenue generated by the transcatheter treatment device market. Based on valve type, the transcatheter treatment device market is segmented into: balloon-expanded valves, self-expanded valves. Among these, the self-expanded valves segment was accounted for the highest revenue generator in 2021. On the basis of region, the transcatheter treatment device market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW). North America captured the largest share of the market in 2021.

The global transcatheter treatment device market is highly competitive. The key players in the transcatheter treatment device market include Abbott Laboratories, Biosensors International Group Ltd., Biotronik SE & Co. KG., Boston Scientific Corporation, Bracco S.p.A., Edwards Lifesciences Corporation, Medtronic plc, Neovasc Inc.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?
– Get a detailed picture of the Global Transcatheter Treatment Device Market
– Identify segments/areas to invest in over the forecast period in the Global Transcatheter Treatment Device Market
– Understand the competitive environment, the market’s leading players
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.

Global Transcatheter Treatment Device Market

Interested in this report? Get your FREE sample now!
Global Transcatheter Treatment Device Market - Report Scope
REPORT ATTRIBUTE

DETAILS

Base Year

2021

Forecast Year

2022-2028

CAGR (2022-2028)

14.3%

Pages

21

Key Players

Abbott Laboratories, Biosensors International Group Ltd., Biotronik SE & Co. KG., Boston Scientific Corporation, Bracco S.p.A., Edwards Lifesciences Corporation, Medtronic plc, Neovasc Inc.

Related Reports
Global Scar Management Market 2023

The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…

READ MORE

$1,350.00

Want to customize this report?
The present report possesses the flexibility to be tailored to your specific needs. Our team of analysts and industry experts will collaborate directly with you to gain a comprehensive understanding of your requirements.
Scroll to Top

Download Free Sample - Global Transcatheter Treatment Device Market

Please fill out our form and we will get back to you.